CV Lattes
ResearcherID
ORCID
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduate at Medicina from Faculdade de Ciências Medicas de Santos/-Fundação Lusíada/SP (1976) and ph.d. at Cardiology from Universidade de São Paulo (1992). Has experience in Medicine, focusing on Cardiology, acting on the following subjects: cardiac pacing and implantable devices, chagas heart desease, cardiac arrhythmias and ressynchronization therapy. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, is a neglected disease affecting around 6 million people, with no effective antiparasitic drugs or vaccines. About 30% of CD patients develop chronic Chagas disease cardiomyopathy (CCC), an inflammatory cardiomyopathy that occurs decades after the initial infection, while most infected patients (60%) remain asymptoma…
Atrial fibrillation is the most prevalent sustained cardiac arrhythmia and is associated with higher mortality. The prevalence of AF increases with heart failure (HF) and can worse its prognosis. Conventional cardiac pacing can correct the occurrence of long-short cycles and RR variability; when there is ventricular dysfunction, ventricular resynchronization therapy (VRT) can prevent intr…
The endocavitary pacing of the right ventricle is recognized as safe and effective in the treatment of symptomatic bradyarrhythmias. However, recent studies have associated this type of stimulation to deleterious effects responsible for installation or worsening of heart failure in patients with reduced left ventricular ejection fraction - LVEF (<35 or 40%). Our hypothesis is that the con…
Chagas disease (ChD) is considered a major public health problem in Latin America and recent estimates suggest about 10 million people infected worldwide. Progression to chronic chagasic cardiomyopathy (CCC) occurs in approximately 20-40% of those infected, and the main causes of death are heart failure (HF) and sudden death (SD). The conduction system is commonly affected and CCC remains…
(Only some records are available in English at this moment)
Chagasic Cardiomyopathy (CCC) is the most important manifestation of Chagas disease, and heart failure (HF) is the leading cause of death; ventricular arrhythmia and advanced atrioventricular block (AVB) are also common and can cause sudden death. To treat the irreversible AVB, a permanent pacemaker (PPM) implantantion is the only alternative, but can cause worsening of HF. Objective: to…
| 1 / 1 | Ongoing grants |
| 7 / 7 | Completed research grants |
| 3 / 1 | Completed scholarships in Brazil |
| 11 / 9 | All research grants and scholarships |
| Associated processes | |